# Formula M-51: Advanced Exercise Mimetic Peptide Blend

**PHYSICIAN USE ONLY | RESEARCH PEPTIDES**

*Last Updated: February 5, 2026*

---

## 1. COMPOSITION & OVERVIEW

Formula M-51 is a powerful, dual-pathway exercise mimetic protocol designed to replicate the metabolic and body composition benefits of physical exercise. It combines a potent NNMT inhibitor with a novel ERR pan-agonist to synergistically enhance cellular energy expenditure and promote a lean phenotype.

| Component | Dosage | Primary Mechanism |
|---|---|---|
| **5-Amino-1MQ** | 50 mg | Nicotinamide N-Methyltransferase (NNMT) Inhibitor |
| **SLU-PP-332** | 1 mg | Pan-ERR (Estrogen-Related Receptor) Agonist |

This formulation targets two distinct but complementary nodes in the regulation of cellular metabolism to increase NAD+ levels, boost energy expenditure, and reduce fat storage, independent of changes in diet or physical activity.

---

## 2. DETAILED MECHANISM OF ACTION

Formula M-51 employs a sophisticated two-pronged strategy to reprogram cellular metabolism.

### 2.1 5-Amino-1MQ: NNMT Inhibition & NAD+ Salvage

5-Amino-1MQ is a small, membrane-permeable molecule that potently and selectively inhibits the enzyme Nicotinamide N-Methyltransferase (NNMT). NNMT is highly expressed in adipose (fat) tissue and plays a key role in regulating cellular energy and NAD+ metabolism.

- **NNMT Inhibition:** By inhibiting NNMT, 5-Amino-1MQ prevents the methylation of nicotinamide, a key step in the NAD+ salvage pathway. This has two major consequences:
    1. **Increased NAD+ Levels:** It increases intracellular concentrations of NAD+, a critical coenzyme for mitochondrial function and a required substrate for sirtuins (longevity proteins) [1]. Declining NAD+ levels are a hallmark of aging and metabolic dysfunction.
    2. **Reduced Fat Storage:** The inhibition of NNMT in adipocytes alters cellular metabolism, increasing energy expenditure and reducing the storage of fat. Preclinical studies show that NNMT inhibition leads to a significant reduction in body weight and fat mass, and can reverse diet-induced obesity [1].

### 2.2 SLU-PP-332: Pharmacological Exercise Mimicry via ERR Agonism

SLU-PP-332 is a first-in-class, orally bioavailable pan-agonist of the Estrogen-Related Receptors (ERRα, ERRβ, ERRγ). These receptors are master regulators of cellular energy metabolism, particularly in high-energy-demand tissues like skeletal muscle [2].

- **ERR Agonism:** Activation of the ERRs by SLU-PP-332 initiates a genetic program that mimics the effects of endurance exercise. This includes the upregulation of genes involved in:
    - **Fatty Acid Oxidation:** Increasing the muscle's ability to burn fat for fuel.
    - **Mitochondrial Biogenesis:** Creating new, more efficient mitochondria.
    - **Krebs Cycle (TCA) Activity:** Boosting the central engine of cellular respiration.
- **Metabolic Reprogramming:** In preclinical models, SLU-PP-332 caused a ~12% reduction in body weight in obese mice, reduced fat mass accumulation, lowered cholesterol and triglycerides, and improved glucose tolerance, all without any change in food intake or physical activity [2].

### 2.3 Synergistic Architecture

The combination of 5-Amino-1MQ and SLU-PP-332 creates a powerful metabolic synergy. 5-Amino-1MQ works primarily in adipose tissue to block fat storage and increase NAD+ levels, essentially making fat cells less efficient at storing energy. Simultaneously, SLU-PP-332 works primarily in muscle tissue to increase its capacity to burn fat and expend energy. The result is a push-pull effect: fat cells are discouraged from storing fat, while muscle cells are primed to burn it. This comprehensive reprogramming of cellular metabolism leads to significant improvements in body composition and overall metabolic health.

---

## 3. CLINICAL INDICATIONS & BENEFITS

Formula M-51 is indicated for individuals seeking to improve body composition, enhance metabolic rate, and achieve the physiological benefits of exercise, particularly those who may be unable to engage in intense physical activity.

| Category | Key Benefits |
|---|---|
| **Body Composition** | Significant reduction in body weight and fat mass; preservation or increase in lean muscle mass; improved waist-to-hip ratio. |
| **Metabolic Rate** | Increased resting energy expenditure; enhanced fatty acid oxidation; improved insulin sensitivity and glucose disposal. |
| **Cellular Health** | Increased intracellular NAD+ levels; enhanced mitochondrial biogenesis and function; activation of sirtuin longevity pathways. |
| **Performance** | Potential for increased endurance and work capacity due to enhanced muscular metabolic efficiency. |

---

## 4. DOSING, ADMINISTRATION & SAFETY

- **Standard Dose:** One capsule daily.
- **Administration:** Can be taken with or without food.
- **Safety Profile:** Both 5-Amino-1MQ and SLU-PP-332 are novel compounds with limited long-term human safety data. Preclinical studies have shown favorable safety profiles with no significant toxicity observed at therapeutic doses.
- **Contraindications:** Pregnancy/lactation; known hypersensitivity.

---

## 5. REFERENCES

[1] Neelakantan, H., et al. (2019). The small molecule NNMT inhibitor, 5-amino-1MQ, reverses diet-induced obesity, insulin resistance and fatty liver disease. *Biochemical Pharmacology*, 167, 103-113. [https://doi.org/10.1016/j.bcp.2019.03.018](https://doi.org/10.1016/j.bcp.2019.03.018)

[2] Billon, C., et al. (2024). A pan-ERR agonist induces a thermogenic-like exercise-mimetic response in muscle. *Journal of Pharmacology and Experimental Therapeutics*, 388(2), 232-240. [https://doi.org/10.1124/jpet.123.001733](https://doi.org/10.1124/jpet.123.001733)
